newsfilter
← Latest News
GlobeNewswire·

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second favorable head-to-head data set from an independent study at large hospital comparing